Biotech

All Articles

F 2G raises $100M for 2nd attempt to obtain new antifungal to market

.After F2G's 1st attempt to receive a brand-new class of antifungal to market was thwarted by the FD...

Moderna targets $1.1 B in R&ampD investing slices, falls 5 systems surrounded by profits tensions

.Moderna has pledged to reduce R&ampD investing through $1.1 billion through 2027. The selection to ...

Sanofi's $80M bank on Fulcrum dystrophy drug ends in stage 3 fail

.Only 4 months after Sanofi wager $80 thousand in upfront cash on Pivot Therapies' losmapimod, the p...

Oncternal share sinks 60% amid layoffs, test firings

.Cancer cells firm Oncternal Rehabs is folding all its own professional trials as well as laying off...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight management in late-stage test

.Roche is actually storing out hopes that its own injectable excessive weight possibility can eventu...

Novo Nordisk barrages 'exceptional' fat loss result for dual-acting oral drug in early test

.Novo Nordisk has lifted the top on a period 1 trial of its dental amylin and also GLP-1 receptor co...

AbbVie sues BeiGene over blood cancer cells drug classified information

.Just a couple of short full weeks after succeeding an FDA Fast Track tag for its investigational BT...

Lilly delivers one-two punch along with second tranche of good records on weekly the hormone insulin prospect

.Soon after a favorable records decrease for Eli Lilly's efsitora alfa, the Indianapolis-based provi...

BridgeBio cuts genetics therapy spending plan as medical records dissatisfy

.BridgeBio Pharma is lowering its own gene treatment budget as well as pulling back from the modalit...

GSK submits HSV vaccine really hopes after stage 2 neglect, resigning ethnicity to Moderna, BioNTech

.GSK's effort to create the first vaccination for genital herpes simplex infection (HSV) has finishe...